SecBot SecBot
SECBOTREPLAY Home › Report › ARTV

ARTV · Four Artiva Biotherapeutics insiders, including the CEO, COO, CTO, and…

Artiva Biotherapeutics, Inc. · CLUSTER filed Sep 9, 2026 at 16:02 ET

At the news

NEUTRALIMPACT 4/10

CLUSTER filed Sep 9, 2026 at 16:02 ET

Four Artiva Biotherapeutics insiders, including the CEO, COO, CTO, and CMO, sold a total of $477K in open-market shares over a one-week window. The CEO's sale of $256K represents the largest portion. These sales occurred alongside a cluster of non-cash equity grants to the same executives, suggesting the sales are likely liquidity-driven to cover tax obligations from vesting awards, rather than a bearish signal on the company's prospects.

  • CEO Fred Aslan sold 23,400 shares for $256K on 2026-09-08.
  • COO Jennifer Bush sold 8,400 shares for $94K on 2026-09-03.
  • CTO Christopher Horan sold 10,400 shares for $116K on 2026-09-03.
  • CMO Subhashis Banerjee sold 1,100 shares for $12K on 2026-09-03.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access